Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
2.380
-0.070 (-2.86%)
At close: Jun 5, 2025, 4:00 PM
2.352
-0.028 (-1.19%)
After-hours: Jun 5, 2025, 4:48 PM EDT
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $64.43 million as of June 5, 2025. Its market cap has decreased by -80.77% in one year.
Market Cap
64.43M
Enterprise Value
-67.99M
1-Year Change
-80.77%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $64.43M, a decrease of -87.81%. That is a compound annual growth rate of -79.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 66.33M | -41.86% |
| Dec 31, 2024 | 114.08M | -78.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.72B |
| Johnson & Johnson | 373.90B |
| AbbVie | 330.30B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 276.42B |
| Abbott Laboratories | 232.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |